Integra Lifesciences Holdings (IART)

Nasdaq Health Care Health Care Equipment S&P SmallCap 600

$13.42

-0.70 (-4.96%)

Close of Nov 06, 2026 · end-of-day data

Source: Integra Lifesciences Holdings's 10-K / 10-Q XBRL data on SEC EDGAR · fetched Nov 02, 2026

Revenue, net income & free cash flow

Income statement

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$992.08M	$1.19B	$1.47B	$1.52B	$1.37B	$1.54B	$1.56B	$1.54B	$1.61B	$1.64B
Cost of revenue	$349.09M	$435.51M	$571.50M	$564.68M	$520.83M	$597.81M	$587.36M	$656.84M	$728.47M	$803.62M
Gross profit	$642.99M	$752.73M	$900.95M	$952.88M	$851.03M	$944.64M	$970.31M	$884.74M	$882.06M	$831.62M
Research & development	$58.16M	$63.45M	$78.04M	$79.57M	$77.38M	$93.05M	$101.19M	$104.19M	$115.38M	$98.97M
Selling, general & admin	$455.63M	$624.10M	$690.75M	$687.60M	$594.53M	$637.45M	$616.32M	$656.64M	$716.98M	$699.70M
Operating income	$115.34M	$44.80M	$111.00M	$93.76M	$151.37M	$197.23M	$238.92M	$111.53M	$28.41M	-$493.37M
Interest expense	$25.80M	$35.02M	$64.68M	$53.96M	$71.58M	$50.40M	$49.59M	$51.38M	$70.63M	$86.25M
Pre-tax income	$90.41M	$11.38M	$57.40M	$60.10M	$93.52M	$214.68M	$213.89M	$81.07M	-$18.24M	-$563.50M
Income tax	$15.84M	-$53.36M	-$3.40M	$9.90M	-$40.37M	$45.60M	$33.34M	$13.33M	-$11.29M	-$47.03M
Net income	$74.56M	$64.74M	$60.80M	$50.20M	$133.89M	$169.07M	$180.55M	$67.74M	-$6.94M	-$516.47M
EBITDA	$188.00M	$133.75M	$221.73M	$203.22M	$193.47M	$236.63M	$279.02M	$152.43M	$70.81M	-$448.57M
EPS (basic)	$1.00	$0.84	$0.73	$0.59	$1.58	$2.00	$2.18	$0.85	$-0.09	$-6.74
EPS (diluted)	$0.94	$0.82	$0.72	$0.58	$1.57	$1.98	$2.16	$0.84	$-0.09	$-6.74
Diluted shares	79.19M	79.12M	84.00M	86.49M	85.23M	85.48M	83.52M	80.34M	77.01M	76.67M
Gross margin	64.8%	63.3%	61.2%	62.8%	62.0%	61.2%	62.3%	57.4%	54.8%	50.9%
Operating margin	11.6%	3.8%	7.5%	6.2%	11.0%	12.8%	15.3%	7.2%	1.8%	-30.2%
Net margin	7.5%	5.4%	4.1%	3.3%	9.8%	11.0%	11.6%	4.4%	-0.4%	-31.6%

Balance sheet

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash & equivalents	$102.06M	$174.94M	$138.84M	$198.91M	$470.17M	$513.45M	$456.66M	$276.40M	$246.38M	$235.05M
Short-term investments	$0	—	—	—	—	—	$0	$32.69M	$27.19M	$28.69M
Receivables	$148.19M	$251.80M	$265.74M	$275.30M	$225.53M	$231.83M	$263.46M	$259.33M	$272.37M	$278.85M
Inventory	$217.26M	$296.33M	$280.35M	$316.05M	$310.12M	$317.39M	$324.58M	$389.61M	$429.09M	$492.74M
Total current assets	$495.17M	$822.15M	$775.08M	$858.17M	$1.24B	$1.15B	$1.16B	$1.06B	$1.08B	$1.16B
Goodwill	$510.57M	$937.90M	$926.48M	$954.28M	$932.37M	$1.01B	$1.04B	$1.06B	$1.10B	$615.16M
Total assets	$1.81B	$3.21B	$3.11B	$3.30B	$3.62B	$3.78B	$3.89B	$3.78B	$4.04B	$3.60B
Total current liabilities	$123.60M	$348.91M	$262.55M	$331.31M	$401.01M	$340.02M	$320.91M	$306.98M	$922.13M	$455.98M
Long-term debt	—	—	$900.00M	$877.50M	$877.50M	$843.75M	$775.00M	$775.00M	$760.47M	$726.56M
Total debt	—	—	$900.00M	$877.50M	$877.50M	$843.75M	$775.00M	$775.00M	$760.47M	$726.56M
Total liabilities	$968.29M	$2.25B	$1.73B	$1.89B	$2.10B	$2.10B	$2.09B	$2.19B	$2.49B	$2.56B
Shareholders' equity	$839.67M	$962.31M	$1.38B	$1.42B	$1.51B	$1.68B	$1.80B	$1.59B	$1.55B	$1.04B

Cash flow

fiscal years · USD

Fiscal year	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Operating cash flow	$116.41M	$114.54M	$199.68M	$231.43M	$203.83M	$312.43M	$264.47M	$139.96M	$129.38M	$50.38M
Capital expenditures	$47.33M	$43.50M	$77.74M	$69.54M	$38.89M	$48.02M	$42.34M	$66.86M	$104.42M	$81.44M
Free cash flow	$69.08M	$71.04M	$121.94M	$161.90M	$164.94M	$264.40M	$222.13M	$73.09M	$24.96M	-$31.05M
Investing cash flow	-$42.62M	-$1.22B	-$49.70M	-$162.67M	-$68.07M	-$161.44M	-$58.58M	-$94.18M	-$390.81M	-$108.06M
Financing cash flow	-$15.12M	$1.17B	-$180.87M	-$8.77M	$121.62M	-$98.23M	-$251.95M	-$229.93M	$237.86M	$28.34M
Share buybacks	—	—	$0	$0	$100.00M	$0	$125.00M	$275.00M	$52.47M	$221.00K
Stock-based compensation	$17.31M	$21.55M	$20.78M	$21.25M	$19.59M	$36.21M	$27.73M	$20.14M	$24.38M	$18.58M
Depreciation & amortization	$72.67M	$88.94M	$110.73M	$109.46M	$42.10M	$39.40M	$40.10M	$40.90M	$42.40M	$44.80M

Income statement

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	$397.04M	$368.87M	$418.18M	$380.83M	$442.65M	$382.65M	$415.61M	$402.06M	$434.93M	$391.92M	$418.76M	$411.18M
Cost of revenue	$170.55M	$162.04M	$192.26M	$180.60M	$193.57M	$188.22M	$206.27M	$195.07M	$214.06M	$174.94M	$199.02M	$201.32M
Gross profit	$226.49M	$206.83M	$225.92M	$200.24M	$249.07M	$194.43M	$209.33M	$206.99M	$220.87M	$216.98M	$219.74M	$209.87M
Research & development	$24.28M	$26.96M	$29.77M	$27.43M	$31.21M	$24.73M	$27.00M	$22.46M	$24.79M	$23.50M	$24.25M	$21.90M
Selling, general & admin	$163.13M	$165.80M	$195.47M	$177.19M	$178.52M	$181.50M	$179.89M	$169.05M	$169.27M	$178.24M	$172.44M	$165.31M
Operating income	$36.05M	$3.96M	-$3.03M	-$8.15M	$35.63M	-$15.50M	-$512.67M	$11.76M	$23.04M	$11.47M	$19.29M	$18.90M
Interest expense	$13.75M	$13.62M	$18.65M	$19.37M	$18.98M	$18.82M	$21.04M	$22.73M	$23.67M	$22.46M	$22.99M	$22.96M
Pre-tax income	$28.86M	-$5.23M	-$15.19M	-$20.36M	$22.54M	-$30.04M	-$530.95M	-$6.82M	$4.31M	-$2.41M	$4.74M	$15.66M
Income tax	$9.02M	-$1.95M	-$2.78M	-$9.67M	$3.11M	-$4.74M	-$46.88M	-$1.42M	$6.01M	$2.21M	$262.00K	$812.00K
Net income	$19.83M	-$3.28M	-$12.40M	-$10.70M	$19.43M	-$25.29M	-$484.07M	-$5.40M	-$1.70M	-$4.62M	$4.48M	$14.85M
EPS (basic)	$0.26	$-0.04	$-0.16	$-0.14	$0.25	$-0.33	$-6.31	$-0.07	$-0.02	$-0.06	$0.06	$0.19
EPS (diluted)	$0.25	$-0.04	$-0.16	$-0.14	$0.25	$-0.33	$-6.31	$-0.07	$-0.02	$-0.06	$0.06	$0.19
Diluted shares	-775.00K	77.73M	77.41M	76.45M	-186.00K	76.46M	76.69M	76.75M	35.00K	76.95M	78.17M	78.58M
Gross margin	57.0%	56.1%	54.0%	52.6%	56.3%	50.8%	50.4%	51.5%	50.8%	55.4%	52.5%	51.0%
Operating margin	9.1%	1.1%	-0.7%	-2.1%	8.0%	-4.0%	-123.4%	2.9%	5.3%	2.9%	4.6%	4.6%
Net margin	5.0%	-0.9%	-3.0%	-2.8%	4.4%	-6.6%	-116.5%	-1.3%	-0.4%	-1.2%	1.1%	3.6%

Balance sheet

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Cash & equivalents	$276.40M	$591.91M	$215.24M	$215.16M	$246.38M	$239.10M	$217.91M	$232.19M	$235.05M	$236.81M	$214.41M	$252.26M
Short-term investments	$32.69M	$71.19M	$81.69M	$62.44M	$27.19M	$34.19M	$35.69M	$35.69M	$28.69M	$28.69M	$59.67M	$59.67M
Receivables	$259.33M	$241.09M	$271.15M	$248.30M	$272.37M	$252.45M	$284.51M	$262.16M	$278.85M	$264.41M	$267.19M	$248.99M
Inventory	$389.61M	$403.42M	$421.77M	$436.93M	$429.09M	$445.42M	$465.13M	$489.11M	$492.74M	$495.04M	$492.00M	$464.45M
Total current assets	$1.06B	$1.42B	$1.11B	$1.10B	$1.08B	$1.11B	$1.14B	$1.14B	$1.16B	$1.17B	$1.19B	$1.19B
Goodwill	$1.06B	$1.04B	$1.10B	$1.12B	$1.10B	$1.11B	$616.43M	$615.20M	$615.16M	$613.25M	$611.14M	$607.83M
Total assets	$3.78B	$4.08B	$4.07B	$4.07B	$4.04B	$4.05B	$3.67B	$3.65B	$3.60B	$3.58B	$3.56B	$3.51B
Total current liabilities	$306.98M	$302.39M	$328.32M	$912.56M	$922.13M	$918.45M	$929.81M	$364.05M	$455.98M	$346.85M	$330.88M	$329.00M
Long-term debt	$775.00M	$775.00M	$770.16M	$765.31M	$760.47M	$755.62M	$745.94M	$736.25M	$726.56M	$716.88M	$707.19M	$697.50M
Total debt	$775.00M	$775.00M	$770.16M	$765.31M	$760.47M	$755.62M	$745.94M	$736.25M	$726.56M	$716.88M	$707.19M	$697.50M
Total liabilities	$2.19B	$2.48B	$2.54B	$2.54B	$2.49B	$2.53B	$2.63B	$2.61B	$2.56B	$2.54B	$2.52B	$2.44B
Shareholders' equity	$1.59B	$1.60B	$1.53B	$1.52B	$1.55B	$1.52B	$1.04B	$1.04B	$1.04B	$1.04B	$1.04B	$1.07B

Cash flow

quarters · USD

Quarter ended	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Operating cash flow	$58.75M	$15.76M	$40.40M	$22.48M	$50.74M	-$11.26M	$8.92M	$40.91M	$11.82M	$9.80M	$22.80M	$95.98M
Capital expenditures	$24.54M	$15.46M	$29.71M	$29.65M	$29.60M	$28.92M	$20.15M	$15.16M	$17.21M	$14.85M	$12.31M	$10.25M
Free cash flow	$34.22M	$291.00K	$10.69M	-$7.16M	$21.14M	-$40.18M	-$11.23M	$25.75M	-$5.40M	-$5.04M	$10.49M	$85.73M
Investing cash flow	-$57.23M	-$53.97M	-$322.20M	-$10.40M	-$4.25M	-$35.92M	-$21.65M	-$15.59M	-$34.91M	-$14.85M	-$43.28M	-$10.25M
Financing cash flow	-$6.89M	$358.68M	-$93.75M	-$19.91M	-$7.15M	$35.38M	-$21.14M	-$10.24M	$24.34M	$8.30M	-$818.00K	-$46.29M
Share buybacks	$0	$0	$50.00M	$0	$2.47M	—	—	$0	$0	—	—	$0
Stock-based compensation	$5.79M	$5.60M	$7.24M	$4.38M	$7.15M	$1.87M	$5.29M	$5.58M	$5.84M	$5.17M	$5.84M	$2.90M

Quarterly figures are rebuilt from the year-to-date totals companies report — Q4 is the full year minus the first nine months, since no 10-Q is filed for it. Values are as filed; later restatements replace earlier ones. Fiscal years are labelled by the calendar year in which they end.